Open letter: European Medicines Agency should remove barriers to access clinical trial data.
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
2014
|
| _version_ | 1826307272705310720 |
|---|---|
| author | Goldacre, B Godlee, F Heneghan, C Tovey, D Lehman, R Chalmers, I Barbour, V Brown, T |
| author_facet | Goldacre, B Godlee, F Heneghan, C Tovey, D Lehman, R Chalmers, I Barbour, V Brown, T |
| author_sort | Goldacre, B |
| collection | OXFORD |
| description | |
| first_indexed | 2024-03-07T07:00:26Z |
| format | Journal article |
| id | oxford-uuid:ff8ee56d-14d3-4683-b52b-0fdcf32ad0ec |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-07T07:00:26Z |
| publishDate | 2014 |
| record_format | dspace |
| spelling | oxford-uuid:ff8ee56d-14d3-4683-b52b-0fdcf32ad0ec2022-03-27T13:45:51ZOpen letter: European Medicines Agency should remove barriers to access clinical trial data.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:ff8ee56d-14d3-4683-b52b-0fdcf32ad0ecEnglishSymplectic Elements at Oxford2014Goldacre, BGodlee, FHeneghan, CTovey, DLehman, RChalmers, IBarbour, VBrown, T |
| spellingShingle | Goldacre, B Godlee, F Heneghan, C Tovey, D Lehman, R Chalmers, I Barbour, V Brown, T Open letter: European Medicines Agency should remove barriers to access clinical trial data. |
| title | Open letter: European Medicines Agency should remove barriers to access clinical trial data. |
| title_full | Open letter: European Medicines Agency should remove barriers to access clinical trial data. |
| title_fullStr | Open letter: European Medicines Agency should remove barriers to access clinical trial data. |
| title_full_unstemmed | Open letter: European Medicines Agency should remove barriers to access clinical trial data. |
| title_short | Open letter: European Medicines Agency should remove barriers to access clinical trial data. |
| title_sort | open letter european medicines agency should remove barriers to access clinical trial data |
| work_keys_str_mv | AT goldacreb openlettereuropeanmedicinesagencyshouldremovebarrierstoaccessclinicaltrialdata AT godleef openlettereuropeanmedicinesagencyshouldremovebarrierstoaccessclinicaltrialdata AT heneghanc openlettereuropeanmedicinesagencyshouldremovebarrierstoaccessclinicaltrialdata AT toveyd openlettereuropeanmedicinesagencyshouldremovebarrierstoaccessclinicaltrialdata AT lehmanr openlettereuropeanmedicinesagencyshouldremovebarrierstoaccessclinicaltrialdata AT chalmersi openlettereuropeanmedicinesagencyshouldremovebarrierstoaccessclinicaltrialdata AT barbourv openlettereuropeanmedicinesagencyshouldremovebarrierstoaccessclinicaltrialdata AT brownt openlettereuropeanmedicinesagencyshouldremovebarrierstoaccessclinicaltrialdata |